Sponsors and CROs still face many of the same site activation and patient enrollment challenges across today's clinical studies. Traditional approaches have not only led…
We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an…
We are all finding ways personally and professionally to meet the challenge posed by COVID-19. …
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based…
The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the…
As the coronavirus continues to spread and dominate the media, we are inundated with advice…
There are many ways a clinical trial can go wrong: There might be delays in site identification, initiation, or…
Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov Below image:…
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech…
After record attendance and a high energy atmosphere at SCOPE 2020 in Orlando last week,…
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical…
SCOPE 2020 is almost upon us! This year, ArcheMedX is helping to shape the conversation…
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.…
Does this scenario ring a bell? Your trial is about to go live - and…
When I first wrote this blog, I anticipated that 2020 would be a year that…
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they…
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck,…
See how the ArcheMedX Platform can transform your organization’s learning and insights